-Outlook Its ploy of Aadhar-hinged cash transfer may have won the Congress political points, but will it really be a game-changer?   State-Wise     40% of the 22 crore Aadhar numbers are in Andhra Pradesh (4.7 crore) and Maharashtra (4 crore)     20% is what the two politically sensitive, Congress-ruled states account for of the 51 districts where DCT will be rolled out     55 lakh Aadhar numbers in TMC-run West Bengal. BJP-ruled Gujarat (57...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...

-Live Mint While natural disasters grab our attention, everyday events like illness drag most people into poverty  In a small town of Gujarat, I met Chandibai, a woman, about 50 years of age. Fifteen years previously, her husband, Gokalji, had owned a general-purpose shop in the town centre. The family also owned a house and some agricultural land. In 1989, Gokalji developed an illness that confined him to bed, sometimes at home...

-The Economic Times Nazia is 10 years old. But, according to a claim filed by Chhattisgarh-based Shaheed Hospital with the Rashtriya Swasthya Bima Yojna (RSBY), she has delivered a baby after a caesarean operation. Mukul (name changed) is only 7. But Agarwal Hospital, Raipur, has made a claim for removing cataract from his eyes. A large number of similar implausible claims, being made by private hospitals enrolled to treat poor patients under...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...